These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 22976764)

  • 1. A novel congenital disorder of glycosylation type without central nervous system involvement caused by mutations in the phosphoglucomutase 1 gene.
    Pérez B; Medrano C; Ecay MJ; Ruiz-Sala P; Martínez-Pardo M; Ugarte M; Pérez-Cerdá C
    J Inherit Metab Dis; 2013 May; 36(3):535-42. PubMed ID: 22976764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Central nervous involvement is common in PGM1-CDG.
    Radenkovic S; Witters P; Morava E
    Mol Genet Metab; 2018 Nov; 125(3):200-204. PubMed ID: 30262252
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Glycogen storage disease-like phenotype with central nervous system involvement in a PGM1-CDG patient.
    Ondruskova N; Honzik T; Vondrackova A; Tesarova M; Zeman J; Hansikova H
    Neuro Endocrinol Lett; 2014; 35(2):137-41. PubMed ID: 24878975
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The congenital disorder of glycosylation in PGM1 (PGM1-CDG) can cause severe cardiomyopathy and unexpected sudden cardiac death in childhood.
    Fernlund E; Andersson O; Ellegård R; Årstrand HK; Green H; Olsson H; Gunnarsson C
    Forensic Sci Int Genet; 2019 Nov; 43():102111. PubMed ID: 31563034
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Metabolic Map into the Pathomechanism and Treatment of PGM1-CDG.
    Radenkovic S; Bird MJ; Emmerzaal TL; Wong SY; Felgueira C; Stiers KM; Sabbagh L; Himmelreich N; Poschet G; Windmolders P; Verheijen J; Witters P; Altassan R; Honzik T; Eminoglu TF; James PM; Edmondson AC; Hertecant J; Kozicz T; Thiel C; Vermeersch P; Cassiman D; Beamer L; Morava E; Ghesquière B
    Am J Hum Genet; 2019 May; 104(5):835-846. PubMed ID: 30982613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphoglucomutase-1 deficiency: Early presentation, metabolic management and detection in neonatal blood spots.
    Conte F; Morava E; Bakar NA; Wortmann SB; Poerink AJ; Grunewald S; Crushell E; Al-Gazali L; de Vries MC; Mørkrid L; Hertecant J; Brocke Holmefjord KS; Kronn D; Feigenbaum A; Fingerhut R; Wong SY; van Scherpenzeel M; Voermans NC; Lefeber DJ
    Mol Genet Metab; 2020; 131(1-2):135-146. PubMed ID: 33342467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Galactose supplementation in phosphoglucomutase-1 deficiency; review and outlook for a novel treatable CDG.
    Morava E
    Mol Genet Metab; 2014 Aug; 112(4):275-9. PubMed ID: 24997537
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in hereditary phosphoglucomutase 1 deficiency map to key regions of enzyme structure and function.
    Beamer LJ
    J Inherit Metab Dis; 2015 Mar; 38(2):243-56. PubMed ID: 25168163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DPM2-CDG: a muscular dystrophy-dystroglycanopathy syndrome with severe epilepsy.
    Barone R; Aiello C; Race V; Morava E; Foulquier F; Riemersma M; Passarelli C; Concolino D; Carella M; Santorelli F; Vleugels W; Mercuri E; Garozzo D; Sturiale L; Messina S; Jaeken J; Fiumara A; Wevers RA; Bertini E; Matthijs G; Lefeber DJ
    Ann Neurol; 2012 Oct; 72(4):550-8. PubMed ID: 23109149
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A new D-galactose treatment monitoring index for PGM1-CDG.
    Perales-Clemente E; Liedtke K; Studinski A; Radenkovic S; Gavrilov D; Oglesbee D; Matern D; Rinaldo P; Tortorelli S; Morava E; Raymond K
    J Inherit Metab Dis; 2021 Sep; 44(5):1263-1271. PubMed ID: 34043239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital disorder of glycosylation type 1T with a novel truncated homozygous mutation in PGM1 gene and literature review.
    Tian WT; Luan XH; Zhou HY; Zhang C; Huang XJ; Liu XL; Chen SD; Tang HD; Cao L
    Neuromuscul Disord; 2019 Apr; 29(4):282-289. PubMed ID: 30737079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for substrate and product recognition in human phosphoglucomutase-1 (PGM1) isoform 2, a member of the α-D-phosphohexomutase superfamily.
    Backe PH; Laerdahl JK; Kittelsen LS; Dalhus B; Mørkrid L; Bjørås M
    Sci Rep; 2020 Mar; 10(1):5656. PubMed ID: 32221390
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel insights into the phenotype and long-term D-gal treatment in PGM1-CDG: a case series.
    Radenkovic S; Johnsen C; Schulze A; Lail G; Guilder L; Schwartz K; Schultz M; Mercimek-Andrews S; Boyer S; Morava E
    Ther Adv Rare Dis; 2023; 4():26330040221150269. PubMed ID: 37181075
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution mass spectrometry glycoprofiling of intact transferrin for diagnosis and subtype identification in the congenital disorders of glycosylation.
    van Scherpenzeel M; Steenbergen G; Morava E; Wevers RA; Lefeber DJ
    Transl Res; 2015 Dec; 166(6):639-649.e1. PubMed ID: 26307094
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ALG1-CDG: a new case with early fatal outcome.
    Rohlfing AK; Rust S; Reunert J; Tirre M; Du Chesne I; Wemhoff S; Meinhardt F; Hartmann H; Das AM; Marquardt T
    Gene; 2014 Jan; 534(2):345-51. PubMed ID: 24157261
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and molecular genetic characterization of two patients with mutations in the phosphoglucomutase 1 (PGM1) gene.
    Ding Y; Li N; Chang G; Li J; Yao R; Shen Y; Wang J; Huang X; Wang X
    J Pediatr Endocrinol Metab; 2018 Jul; 31(7):781-788. PubMed ID: 29858906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie.
    Imbach T; Schenk B; Schollen E; Burda P; Stutz A; Grunewald S; Bailie NM; King MD; Jaeken J; Matthijs G; Berger EG; Aebi M; Hennet T
    J Clin Invest; 2000 Jan; 105(2):233-9. PubMed ID: 10642602
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complementation cloning identifies CDG-IIc, a new type of congenital disorders of glycosylation, as a GDP-fucose transporter deficiency.
    Lübke T; Marquardt T; Etzioni A; Hartmann E; von Figura K; Körner C
    Nat Genet; 2001 May; 28(1):73-6. PubMed ID: 11326280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oral D-galactose supplementation in PGM1-CDG.
    Wong SY; Gadomski T; van Scherpenzeel M; Honzik T; Hansikova H; Holmefjord KSB; Mork M; Bowling F; Sykut-Cegielska J; Koch D; Hertecant J; Preston G; Jaeken J; Peeters N; Perez S; Nguyen DD; Crivelly K; Emmerzaal T; Gibson KM; Raymond K; Abu Bakar N; Foulquier F; Poschet G; Ackermann AM; He M; Lefeber DJ; Thiel C; Kozicz T; Morava E
    Genet Med; 2017 Nov; 19(11):1226-1235. PubMed ID: 28617415
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diseases of glycosylation beyond classical congenital disorders of glycosylation.
    Hennet T
    Biochim Biophys Acta; 2012 Sep; 1820(9):1306-17. PubMed ID: 22343051
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.